Stem Cell Therapy in Regenerative Medicine Current Progress, Challenges, and Future Prospects.
DOI:
https://doi.org/10.52783/jns.v14.3489Keywords:
Stem cell therapy, regenerative medicine, pluripotent cells, tissue engineering, clinical applications, ethical challenges, future prospects, iPSCsAbstract
Stem cell therapy has emerged as a cornerstone of regenerative medicine, offering revolutionary potential for the treatment of a myriad of degenerative diseases, injuries, and organ dysfunctions. The unique ability of stem cells to self-renew and differentiate into specialized cell types has enabled researchers and clinicians to explore novel therapeutic strategies aimed at restoring or replacing damaged tissues. Over the past two decades, significant advancements have been made in stem cell research, including the identification and classification of different types of stem cells such as embryonic stem cells (ESCs), adult stem cells (ASCs), and induced pluripotent stem cells (iPSCs). These developments have paved the way for promising clinical applications, including the regeneration of cardiac tissue post-myocardial infarction, spinal cord injury repair, and treatment of hematological disorders.
Despite these advancements, stem cell therapy faces numerous scientific, ethical, and regulatory challenges. Key hurdles include immune rejection, tumorigenicity, limited cell survival and integration, and ethical debates surrounding the use of ESCs. Moreover, translating laboratory findings into effective clinical therapies remains a complex and lengthy process that involves rigorous testing, standardization of protocols, and stringent regulatory oversight. Additionally, the scalability of stem cell production and ensuring reproducibility across diverse patient populations are major concerns that need to be addressed.
Nevertheless, the future prospects of stem cell therapy remain optimistic, driven by breakthroughs in gene editing technologies, 3D bioprinting, and organoid development. The convergence of stem cell biology with other fields such as nanotechnology, artificial intelligence, and personalized medicine is expected to enhance the precision and efficacy of regenerative treatments. Ongoing clinical trials and interdisciplinary research initiatives continue to bring stem cell-based interventions closer to routine clinical practice.
This paper aims to provide a comprehensive overview of the current state of stem cell therapy in regenerative medicine. It explores recent progress in stem cell research, discusses the major challenges hindering clinical translation, and highlights future directions that may shape the next generation of regenerative therapies. By synthesizing the latest scientific insights and technological innovations, this review seeks to contribute to a better understanding of stem cell therapy's transformative potential in modern medicine.
Downloads
Metrics
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.